Monday, October 12, 2026

USD/EUR Went Up By Over 1% In The Last 21 Sessions

ViaNews Editorial Team

November 6, 2023

USD/EUR Went Up By Over 1% In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 1.61% for the last 21 sessions. At 22:13 EST on Sunday, 5 November, USD/EUR (USDEUR) is $0.93.

USD/EUR's yearly highs and lows, it's 5.04% up from its 52-week low and 7.589% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.06%, a negative 0.05%, and a positive 0.28%, respectively.

USD/EUR's highest amplitude of average volatility was 0.23% (last week), 0.28% (last month), and 0.28% (last quarter), respectively.

News about

  • According to FXStreet on Friday, 3 November, "(This story was corrected on November 3 at 11:58 GMT to say that the EUR/USD pair extended positive price action on Friday, not Thursday.)", "The Euro (EUR) preserves its positively robust sentiment in the latter half of the week against the US Dollar (USD), motivating EUR/USD to revisit the 1.0650 region prior to the release of the US employmentreport on Friday."
  • Eur/usd to end the year around the 1.05/1.06 area – ING. According to FXStreet on Friday, 3 November, "Given our house view that a US slowdown is more likely in the next quarter rather than this one, we therefore expect EUR/USD to end the year around this 1.05/1.06 area and USD/JPY to end the year not far from 150. ", "Our forecast for a Eurozone recession, a difficult return of the Stability and Growth Pact, and the ongoing threat of a geopolitical spike in oil prices present downside risks to our view of a Fed-driven rise in EUR/USD to 1.10 next summer and 1.15 by year-end 2024."
  • According to FXStreet on Friday, 3 November, "Although EUR/USD erased a portion of its daily gains in the American session, it closed in positive territory on Thursday. "
  • According to FXStreet on Friday, 3 November, "An upbeat NFP headline print and hot wage inflation data could reignite expectations of a December Fed rate hike, offering much-needed support to the US Dollar while dragging EUR/USD back toward 1.0500. ", "Dhwani Mehta, Analyst at FXStreet, offers a brief technical outlook for trading EUR/USD on the NFP data release. "
  • Eur/usd price analysis: remains below 50-day sma, bearish flag pattern in play ahead of NFP. According to FXStreet on Friday, 3 November, "That said, the recent repeated failures near the 50-day Simple Moving Average (SMA) warrants caution before placing bullish bets around the EUR/USD pair. ", "Hence, the 1.0665-1.0670 area might continue to act as an immediate strong barrier, above which the EUR/USD pair could aim to reclaim the 1.0700 mark and test the top boundary of the aforementioned trend channel, currently around the 1.0715 region. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,371 source documents archived
Query this data → isubstrate.com